[Effectiveness of propafenone in congenital ectopic junctional tachycardia--a case report].
Junctional ectopic tachycardia is associated with a poor prognosis when it occurs in newborns and young infants. Like other automatic tachyarrhythmias, junctional ectopic tachycardia has been shown to be very resistant to medical treatment. Successful therapy with propafenone in a newborn with congenital junctional ectopic tachycardia is presented. Due to its high effectiveness, safety, and lack of side-effects, propafenone appears to be a valuable drug in the treatment of young patients with congenital junctional ectopic tachycardia.
Paul
T
T
Abt. Kinderheilkunde III, Medizinische Hochschule Hannover.
Reimer
A
A
Kallfelz
H C
HC
D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D015716:Electrocardiography, Ambulatory / Q000187:drug effects*; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011405:Propafenone / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013613:Tachycardia, Ectopic Junctional / Q000151:congenital* / Q000188:drug therapy / Q000503:physiopathology
D011405:Propafenone
Effektivität von Propafenon bei kongenitaler junktionaler ektoper Tachykardie--ein Fallbericht.